Avid Bioservices Inc (CDMO)

[sulaco]

Wup, I don't see a problem with your post


I do see a problem with your perspective, though. Very significant jumps in valuation are fairly common in biotech. ICPT, ARNA, GILD. I mean, if you've held Gilead for the past 2-3 years, you've got 7-8 bagger. Look at its chart.

Gilead bought out Pharmasset's phase II hepatitis drug for $12 billion. 12 BILLION. For a Phase II drug.

$12 billion would put PPHM's share price at $67.

Would you have a problem with that?

Or do you think that a phase II hepatitis drug really is more valuable than Bavituximab.

You can think that if you want to.

It's just that I do not.


Best,

Joe